<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02062437</url>
  </required_header>
  <id_info>
    <org_study_id>1301-T-CERAM-R</org_study_id>
    <nct_id>NCT02062437</nct_id>
  </id_info>
  <brief_title>Clinical and Radiological Results of Total Hip Arthroplasty Using a Ceramic Friction Pair</brief_title>
  <acronym>CERAM</acronym>
  <official_title>Multicentric Observational Study Evaluating Clinical and Radiological Results of a Total Hip Arthroplasty Using a Ceramic Friction Pair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tornier, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tornier, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to assess safety and general performance of total hip arthroplasty,
      composed of a Meije Duo® femoral stem associated with a Dynacup® cup, and using the friction
      pair Biolox® Delta Ceramic.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Adverse Events</measure>
    <time_frame>2-year follow-up visit</time_frame>
    <description>Surgical incidents.
Post-operative complications.
Failure and revisions analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>General Performance: Mobility</measure>
    <time_frame>Baseline</time_frame>
    <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Performance: Mobility</measure>
    <time_frame>2-year Follow-up visit</time_frame>
    <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>General Performance: Objective Clinical Score (PMA)</measure>
    <time_frame>Baseline</time_frame>
    <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
  </other_outcome>
  <other_outcome>
    <measure>General Performance: Objective Clinical Score (PMA)</measure>
    <time_frame>2-year follow-up visit</time_frame>
    <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
  </other_outcome>
  <other_outcome>
    <measure>General Performance: Radiological Assessment.</measure>
    <time_frame>2-year Follow-up visit</time_frame>
    <description>Radiological assessment is based on :
Cup radiological signs of osteolysis or radiolucencies.
Stem radiological signs of osteolysis or radiolucencies.
Ossifications according to Brooker classification from class I: Ossification around the hip joint. to class IV: shows apparent bone ankylosis of the hip. (i.e Class 0 = no ossification)
Other Radiological signs</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Hip Replacement</condition>
  <condition>Primary, Secondary or Post-traumatic Osteoarthrosis</condition>
  <condition>Femur Head Necrosis</condition>
  <condition>Congenital Dislocations</condition>
  <arm_group>
    <arm_group_label>Total hip replacement using a ceramic friction pair</arm_group_label>
    <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Cohort of European patients with a primary total hip replacement using a ceramic friction
        pair including Meije Duo® stem associated with a Dynacup® cup.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female patient implanted with a primary total hip replacement using a ceramic
             friction pair including Meije Duo® stem associated with a Dynacup® cup.

          -  Aged of more than 18 years at the time of the surgery.

          -  Patient with a follow-up of at least 2 years after surgery based on a consecutive and
             exhaustive series of patients operated within the inclusion period.

          -  Able to understand information to participate to the study.

        Exclusion Criteria:

          -  Patient having a tumoral pathology.

          -  Patient having expressed opposition to the study participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Piriou, MD, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Universitaire Raymond Poincaré, Garches - France</affiliation>
  </overall_official>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2014</study_first_submitted>
  <study_first_submitted_qc>February 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2014</study_first_posted>
  <results_first_submitted>December 9, 2015</results_first_submitted>
  <results_first_submitted_qc>March 25, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">April 28, 2016</results_first_posted>
  <last_update_submitted>May 2, 2017</last_update_submitted>
  <last_update_submitted_qc>May 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthroplasty</keyword>
  <keyword>Hip Replacement</keyword>
  <keyword>Ceramic</keyword>
  <keyword>Acetabular cup</keyword>
  <keyword>Femoral stem</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Necrosis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Femur Head Necrosis</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All patients who received the same Total Hip Replacement system for primary hip replacement between July and October 2010 were contacted for study participation.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
          <description>All patients were treated with a total hip replacement using a ceramic friction pair Biolox® delta, with a Meije Duo® cementless stem with HAP associated with a cementless double coating of plasma sprayed titanium and HAP Dynacup® acetabular cup.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="132">132 patients who undergone THR (July-Oct 2010), complying with in/exclusion criteria were identified</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="80">80 patients were effectively enrolled, when coming back for their 2-year follow-up visit.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Pt. didn't want to come for the 2y visit</title>
              <participants_list>
                <participants group_id="P1" count="31"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Patient not available for the 2y visit</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Pt. couldn't come due to med. condition</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>132 eligible patients were identified and contacted by the investigators: all patients were still implanted with the same THR system when contacted for study participation, including 2 patients who died before this contact: 80 patients were enrolled and completed the study per protocol at the 2-year follow-up visit without any protocol deviations.</population>
      <group_list>
        <group group_id="B1">
          <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
          <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.8" spread="9.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Adverse Events</title>
        <description>Surgical incidents.
Post-operative complications.
Failure and revisions analysis.</description>
        <time_frame>2-year follow-up visit</time_frame>
        <population>The total of 80 patients were seen for their 2-Year follow-up visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Adverse Events</title>
          <description>Surgical incidents.
Post-operative complications.
Failure and revisions analysis.</description>
          <population>The total of 80 patients were seen for their 2-Year follow-up visit.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>General Performance: Mobility</title>
        <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
        <time_frame>Baseline</time_frame>
        <population>80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>General Performance: Mobility</title>
          <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
          <population>80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Extension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Flexion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>External rotation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Internal rotation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>General Performance: Objective Clinical Score (PMA)</title>
        <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
        <time_frame>Baseline</time_frame>
        <population>Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>General Performance: Objective Clinical Score (PMA)</title>
          <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
          <population>Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mobility score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.1" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walking score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total PMA score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.5" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>General Performance: Mobility</title>
        <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
        <time_frame>2-year Follow-up visit</time_frame>
        <population>80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>General Performance: Mobility</title>
          <description>Mobility of the hip is assessed by the maximum value in the range of motions, expressed in degrees (°).
Normal values (usually observed range of motions) are:
extension (from 0 to 30°), flexion (from 0 to 120°), abduction (from 0 to 45°), adduction (from 0 to 30°), external rotation (from 0 to 45°) and internal rotation (from 0 to 45°).
Higher values are the best and a negative value indicates that the patient(s) can't reach the minimum normal range of motion.</description>
          <population>80 patients were available but per-protocol some pre-operative data were not available for the analysis of mobilities</population>
          <units>Degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="45"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Extension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Flexion</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" spread="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Adduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Abduction</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>External rotation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Internal rotation</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>General Performance: Objective Clinical Score (PMA)</title>
        <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
        <time_frame>2-year follow-up visit</time_frame>
        <population>Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>General Performance: Objective Clinical Score (PMA)</title>
          <description>Postel Merle d'Aubigne (PMA) rating contains three items; pain, function and hip mobility; each noted 0 to 6 points (0 is the worst possible score and 18 is the best possible PMA score).</description>
          <population>Within per protocol population, data were not complete to calculate the total PMA score for 3 patients at 2-year visit.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="77"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Pain score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Mobility score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.0" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Walking score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="0.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total PMA score</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.7" spread="1.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>General Performance: Radiological Assessment.</title>
        <description>Radiological assessment is based on :
Cup radiological signs of osteolysis or radiolucencies.
Stem radiological signs of osteolysis or radiolucencies.
Ossifications according to Brooker classification from class I: Ossification around the hip joint. to class IV: shows apparent bone ankylosis of the hip. (i.e Class 0 = no ossification)
Other Radiological signs</description>
        <time_frame>2-year Follow-up visit</time_frame>
        <population>Patients with X-ray data available</population>
        <group_list>
          <group group_id="O1">
            <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
            <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
          </group>
        </group_list>
        <measure>
          <title>General Performance: Radiological Assessment.</title>
          <description>Radiological assessment is based on :
Cup radiological signs of osteolysis or radiolucencies.
Stem radiological signs of osteolysis or radiolucencies.
Ossifications according to Brooker classification from class I: Ossification around the hip joint. to class IV: shows apparent bone ankylosis of the hip. (i.e Class 0 = no ossification)
Other Radiological signs</description>
          <population>Patients with X-ray data available</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="80"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Cups without radiological signs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Stems without radiological signs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ossifications (Brooker classification = 0)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ossifications (Brooker classification = 1)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ossifications (Brooker classification = 2)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ossifications (Brooker classification = 3)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ossifications (Brooker classification = 4)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other radiological signs</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>2 years</time_frame>
      <desc>Adverse events were collected from surgery to last follow-up visit</desc>
      <group_list>
        <group group_id="E1">
          <title>Total Hip Replacement Using a Ceramic Friction Pair</title>
          <description>Patients treated with total hip replacement using a ceramic friction pair Biolox® Delta, with Meije Duo® stem associated with Dynacup® cup</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Femoral fracture</sub_title>
                <description>Spiroid fracture of the thighbone due to patient fall 2 weeks after surgery.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Fracture during surgery</sub_title>
                <description>Partial fracture of the Merckel, no additional procedure has been performed during the surgery.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="80"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Nathalie Trétout</name_or_title>
      <organization>Tornier SAS</organization>
      <phone>+33 4 76 71 35 00</phone>
      <email>nathalie.tretout@tornier.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

